| 000 | 01679cam a22002894a 4500 | ||
|---|---|---|---|
| 001 | 16281343 | ||
| 003 | OSt | ||
| 005 | 20250205152032.0 | ||
| 008 | 100608s2011 njua b 001 0 eng | ||
| 010 | _a 2010023288 | ||
| 016 | 7 |
_a101532762 _2DNLM |
|
| 020 | _a9780470555170 (cloth) | ||
| 020 | _a0470555173 (cloth) | ||
| 035 | _a(OCoLC)ocn642278451 | ||
| 040 |
_aDNLM/DLC _cDLC _dYDX _dNLM _dYDXCP _dBWX _dCDX _dBDX _dDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aHD9665.5 _b.R44 2011 |
| 100 | 1 | _aRees, Hedley. | |
| 245 | 1 | 0 |
_aSupply chain management in the drug industry : _bdelivering patient value for pharmaceuticals and biologics / _cHedley Rees. |
| 260 |
_aHoboken, N.J. : _bWiley, _cc2011. |
||
| 300 |
_axxiii, 432 p. : _bill. ; _c25 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 520 | _a"This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials"--Provided by publisher. | ||
| 650 | 0 |
_aPharmaceutical industry _xMaterials management. |
|
| 650 | 1 | 2 |
_aDrug Industry _xorganization & administration. |
| 942 |
_2lcc _cBK |
||
| 999 |
_c20617 _d20616 |
||